Life Sciences—building new capabilities that advance human health.

The partners have experience in almost all phases of drug and medical device development including novel delivery systems, from ideation to clinical trials.

We are helping our clients define the value of technologies that advance the ability to target cancers both through new classes of therapeutics as well as cancer characterization at the cellular and sub-cellular level. We lead the development and validation of the value proposition with investors and commercial firms. We help advance the opportunity by recruiting corporate co-development partners and / or investors for new start-up firms with compelling technologies in competitive markets.